{"id":10294,"date":"2018-06-08T17:59:18","date_gmt":"2018-06-08T15:59:18","guid":{"rendered":"https:\/\/okomeds.com\/?p=10294\/"},"modified":"2020-08-31T20:15:30","modified_gmt":"2020-08-31T18:15:30","slug":"new-discoveries-can-speed-clinical-translation","status":"publish","type":"post","link":"https:\/\/okomeds.com\/es\/new-discoveries-can-speed-clinical-translation\/","title":{"rendered":"New discoveries can speed clinical translation"},"content":{"rendered":"

Clinical translation can speed the knowledge that new discoveries imply and it can even serve to increase the research related to the discovery and its application. As an example, we are going to pick a recent discovery concerning stem cell therapies. We are referring to a new more efficient approach that consists on reprogramming diseased skin cells into stem cells for any patient.<\/span><\/p>\n

With a precedent in 2006, the main importance of this discovery is that as regenerative medicine, it implies unlimited source of patient-specific cells suitable for transplantation. Therefore, Okomeds, as a life-science translation provider, and CROs translation provider, is interested in echoing this interesting discovery that has already arisen much interest among the medical community.<\/span><\/p>\n

It is also important to point out that in the referred to case, the immature embryonic stem cells that are been reprogrammed, can be grown in or outside the body, transplanted or used for research and genetically manipulated. However, the technology, although promising is not yet well enough developed to guarantee safety for clinical applications.<\/span><\/p>\n

 <\/p>\n\r\n CROs role is crucial when there is a shift from the laboratory to clinical trials

Tweet!<\/div><\/a>\r\n